Published in Lancet on July 31, 1993
Ischaemic preconditioning. BMJ (1994) 10.92
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev (2007) 2.14
Apoptosis in myocardial ischaemia and infarction. J Clin Pathol (2002) 1.59
Repolarisation and refractoriness during early ischaemia in humans. Heart (2000) 1.57
Impact of nicorandil in angina: subgroup analyses. Heart (2004) 1.50
Metabolic downregulation: a key to successful neuroprotection? Stroke (2008) 1.33
Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart (1997) 1.25
Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion. Cardiovasc Res (2009) 1.18
Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res (2009) 1.10
Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study. Heart (2006) 1.10
Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest (1996) 1.09
Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol (2016) 1.08
Cardioprotection during cardiac surgery. Cardiovasc Res (2012) 1.03
The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. Dis Model Mech (2014) 0.99
CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice. Am J Physiol Heart Circ Physiol (2007) 0.99
Is there a place for cerebral preconditioning in the clinic? Transl Stroke Res (2010) 0.96
Effects of acute coronary occlusion and previous ischaemic injury on left ventricular wall motion in humans. Heart (1997) 0.95
Redox signaling pathways involved in neuronal ischemic preconditioning. Curr Neuropharmacol (2012) 0.95
A synopsis of research in cardiac apoptosis and its application to congestive heart failure. Tex Heart Inst J (2007) 0.94
Activation of cardiac muscarinic M3 receptors induces delayed cardioprotection by preserving phosphorylated connexin43 and up-regulating cyclooxygenase-2 expression. Br J Pharmacol (2010) 0.93
The ability of heat stress and metabolic preconditioning to protect primary rat cardiac myocytes. Basic Res Cardiol (1996) 0.93
Ischemic preconditioning reduces endoplasmic reticulum stress and upregulates hypoxia inducible factor-1α in ischemic kidney: the role of nitric oxide. J Biomed Sci (2012) 0.92
Intermittent ischaemic arrest and cardioplegia in coronary artery surgery: coming full circle? Br Heart J (1994) 0.92
Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection. J Clin Invest (1995) 0.92
Myocardial protection in man--from research concept to clinical practice. Heart Fail Rev (2007) 0.92
A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. Basic Res Cardiol (2011) 0.91
Is warm-up in angina ischaemic preconditioning? Br Heart J (1994) 0.90
Investigation of reperfusion injury and ischemic preconditioning in microsurgery. Microsurgery (2009) 0.88
Nitrite as a mediator of ischemic preconditioning and cytoprotection. Nitric Oxide (2011) 0.88
Hydrogen sulfide-mediated myocardial pre- and post-conditioning. Expert Rev Clin Pharmacol (2011) 0.87
Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation. J Transplant (2012) 0.86
Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc Health Risk Manag (2007) 0.86
A small molecule activator of AKT does not reduce ischemic injury of the rat heart. J Transl Med (2015) 0.84
Autophagy, a process within reperfusion injury: an update. Int J Clin Exp Pathol (2014) 0.84
Therapeutic potential of ischaemic preconditioning. Br J Clin Pharmacol (2000) 0.82
Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery. J Saudi Heart Assoc (2013) 0.81
Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation. Immunology (1997) 0.81
Adjuvant cardioprotection in cardiac surgery: update. Biomed Res Int (2014) 0.81
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. FASEB J (2010) 0.80
Organ preconditioning: the past, current status, and related lung studies. J Zhejiang Univ Sci B (2006) 0.80
The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury. Heart (2007) 0.80
Effect of ischemic preconditioning on P-selectin expression in hepatocytes of rats with cirrhotic ischemia-reperfusion injury. World J Gastroenterol (2003) 0.79
The role of free radicals in endogenous adaptation and intracellular signals. Exp Clin Cardiol (2004) 0.78
The role of myocardial ischaemic preconditioning during beating heart surgery: biological aspect and clinical outcome. Interact Cardiovasc Thorac Surg (2011) 0.78
New technique of local ischemic preconditioning induction without repetitive aortic cross-clamping in cardiac surgery. J Cardiothorac Surg (2015) 0.77
Potassium-induced conversion of ventricular fibrillation after aortic declamping. Interact Cardiovasc Thorac Surg (2012) 0.77
Novel therapeutic strategies for ischemic heart disease. Pharmacol Res (2014) 0.77
The ischemic preconditioning effect of adenosine in patients with ischemic heart disease. Cardiovasc Ultrasound (2009) 0.77
Adenosine and ischemic preconditioning. Curr Pharm Des (1999) 0.77
Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial. J Thromb Thrombolysis (1998) 0.77
Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening. J Cell Mol Med (2017) 0.76
Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study-A Single-Center, Blinded, Randomized Controlled Trial. Clin Cardiol (2016) 0.76
Hypotheses, rationale, design, and methods for evaluation of ischemic preconditioning assessed by sequential exercise tests in diabetic and non-diabetic patients with stable coronary artery disease--a prospective study. BMC Cardiovasc Disord (2013) 0.76
Chronic lower extremity ischemia: a human model of ischemic tolerance. Can J Surg (2004) 0.76
Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection? Br J Clin Pharmacol (1994) 0.76
Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts. Basic Res Cardiol (1997) 0.76
Coronary bypass grafting using crossclamp fibrillation does not result in reliable reperfusion of the myocardium when the crossclamp is intermittently released: a prospective cohort study. J Cardiothorac Surg (2006) 0.76
Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease. Medicine (Baltimore) (2015) 0.75
Myocardial conditioning techniques in off-pump coronary artery bypass grafting. J Cardiothorac Surg (2015) 0.75
Establishment of a chronic left ventricular aneurysm model in rabbit. J Geriatr Cardiol (2014) 0.75
Is there a role for ischaemic conditioning in cardiac surgery? F1000Res (2017) 0.75
Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives. Heart Fail Rev (2016) 0.75
The virtue of just enough stress: a molecular model. Trans Am Clin Climatol Assoc (2012) 0.75
Harnessing the preconditioning phenomenon: does remote organ ischaemia provide the answer? Heart (2005) 0.75
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept. Pharmaceuticals (Basel) (2010) 0.75
Improvement in cardioplegic perfusion technique in single aortic clamping - initial results. Rev Bras Cir Cardiovasc (2014) 0.75
Recent advances in cardiology. Postgrad Med J (1994) 0.75
Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.75
Regulation of ion channels in myocardial cells and protection of ischemic myocardium. Heart Fail Rev (2000) 0.75
The influence of the time period between preconditioning ischemia and prolonged ischemia on myocardial protection. Cardioscience (1993) 1.87
Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart (1997) 1.25
Coronary artery fistulas presenting with bacterial endocarditis. Ann Thorac Surg (1995) 1.06
Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol (1995) 1.05
Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke (1998) 1.01
Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. J Mol Cell Cardiol (1995) 1.01
Secundum atrial septal defect repair: long-term surgical outcome and the problem of late mitral regurgitation. Postgrad Med J (1993) 1.01
Penetrating cardiac nail gun injury. Emerg Med J (2008) 0.96
Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res (1992) 0.94
Open lung biopsy for investigation of acute respiratory episodes in patients with HIV infection and AIDS. Genitourin Med (1995) 0.91
A comparison between ischemic preconditioning, intermittent cross-clamp fibrillation and cold crystalloid cardioplegia for myocardial protection during coronary artery bypass graft surgery. Cardiovasc Surg (2002) 0.89
The incidence of significant pericardial effusion and tamponade following major aortic root surgery. J Cardiovasc Surg (Torino) (1996) 0.87
Supravalvar aortic stenosis: unexpected findings at surgery. Heart (1998) 0.86
Role of acadesine in clinical myocardial protection. Br Heart J (1995) 0.85
The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res (2002) 0.84
Recurrent left atrial myxoma. Cardiovasc Surg (1994) 0.83
Ischaemic preconditioning and cardiac surgery. Eur J Cardiothorac Surg (1996) 0.81
Preconditioning the human heart during aorto-coronary bypass surgery. Eur J Cardiothorac Surg (1994) 0.79
Time relationships in the diagnosis and treatment of left-atrial myxoma. Thorac Cardiovasc Surg (1993) 0.79
Penetrating cardiac nail gun injury. BMJ Case Rep (2009) 0.77
Partial cardiopulmonary bypass for the treatment of profound accidental hypothermic circulatory collapse. J R Soc Med (1992) 0.75
Raised international normalised ratio (INR): is it a cause or an effect of late cardiac tamponade? Br Heart J (1992) 0.75
Autoimmune enteropathy with goblet cell antibodies. J R Soc Med (1999) 0.75
Experience with circulatory arrest and hypothermia to facilitate thoracic aortic surgery. Ann R Coll Surg Engl (1989) 0.75
An unusual "internal" penetrating liver injury. BMJ Case Rep (2009) 0.75
Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma. Br J Dis Chest (1982) 0.75
Early to midterm results with the radial artery in coronary artery bypass grafting following autotransplantation without pharmacological manipulation. J Card Surg (2007) 0.75
An unusual "internal" penetrating liver injury. Emerg Med J (2008) 0.75
Surgical management of transposition of great arteries associated with multiple ventricular septal defects. Eur J Cardiothorac Surg (1999) 0.75
Extreme cardiac and pulmonary artery compression causing positional oxygen desaturation. Emerg Med J (2008) 0.75
Comparison of the protective effects of a highly selective ATP-sensitive potassium channel opener and ischemic preconditioning in isolated human atrial muscle. Cardiovasc Drugs Ther (1997) 0.75